ATE204870T1 - Verfahren zur herstellung von paroxetine - Google Patents

Verfahren zur herstellung von paroxetine

Info

Publication number
ATE204870T1
ATE204870T1 AT97108806T AT97108806T ATE204870T1 AT E204870 T1 ATE204870 T1 AT E204870T1 AT 97108806 T AT97108806 T AT 97108806T AT 97108806 T AT97108806 T AT 97108806T AT E204870 T1 ATE204870 T1 AT E204870T1
Authority
AT
Austria
Prior art keywords
represented
general formula
alkoxycarbonylpiperidine
paroxetine
producing
Prior art date
Application number
AT97108806T
Other languages
English (en)
Inventor
Shu-Zhong Wang
Yasushi Matsumura
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Application granted granted Critical
Publication of ATE204870T1 publication Critical patent/ATE204870T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT97108806T 1996-05-31 1997-06-02 Verfahren zur herstellung von paroxetine ATE204870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13904896A JP3882224B2 (ja) 1996-05-31 1996-05-31 パロキセチンの製造方法

Publications (1)

Publication Number Publication Date
ATE204870T1 true ATE204870T1 (de) 2001-09-15

Family

ID=15236260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97108806T ATE204870T1 (de) 1996-05-31 1997-06-02 Verfahren zur herstellung von paroxetine

Country Status (9)

Country Link
US (2) US6433179B1 (de)
EP (1) EP0810225B1 (de)
JP (1) JP3882224B2 (de)
AT (1) ATE204870T1 (de)
CA (1) CA2205770A1 (de)
DE (1) DE69706366T2 (de)
ES (1) ES2162156T3 (de)
PT (1) PT810225E (de)
SI (1) SI0810225T1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384711A1 (de) 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
SI0994872T1 (de) * 1997-06-10 2001-08-31 Synthon Bv
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9916187D0 (en) * 1999-07-09 1999-09-08 Smithkline Beecham Plc Novel process
WO2001085688A1 (en) 2000-05-12 2001-11-15 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
WO2002006275A1 (en) * 2000-07-17 2002-01-24 Smithkline Beecham P.L.C. Novel processes for the preparation of 4-phenylpiperidine derivatives
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
JP2005524656A (ja) * 2002-02-22 2005-08-18 テバ ファーマシューティカル インダストリーズ リミティド 新規中間物質を用いるパロキセチンの調製
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
US20090136982A1 (en) 2005-01-18 2009-05-28 Biocept, Inc. Cell separation using microchannel having patterned posts
KR20070116585A (ko) 2005-01-18 2007-12-10 바이오셉트 인코포레이티드 패턴화된 포스트를 갖는 마이크로채널을 이용하는 세포분리법
WO2007015262A2 (en) * 2005-04-25 2007-02-08 Sun Pharmaceutical Industries Limited A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine
AU2006315684A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CN102718756B (zh) * 2012-07-02 2013-11-20 浙江尖峰药业有限公司 盐酸帕罗西汀化合物及其合成方法
CN104447714A (zh) * 2014-11-18 2015-03-25 成都医路康医学技术服务有限公司 一种盐酸帕罗西汀的生产工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4268515A (en) * 1980-02-04 1981-05-19 Hoechst-Roussel Pharmaceuticals Inc. Spiro[dihydrobenzofuran-piperidines and-pyrrolidines], pharmaceutical compositions thereof and methods of use thereof
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
EP0190496A3 (de) 1984-12-13 1987-05-27 Beecham Group Plc Piperidinderivate mit gastro-intestinaler Wirkung
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
IE66332B1 (en) 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5227379A (en) 1986-11-03 1993-07-13 Novo Nordisk A/S Piperidine compounds and their preparation and use
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
JP2607784B2 (ja) 1991-09-30 1997-05-07 株式会社神戸製鋼所 廻し溶接用エンドタブ
SK283608B6 (sk) 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384711A1 (de) 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
GB9817195D0 (en) * 1998-08-07 1998-10-07 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
JP3882224B2 (ja) 2007-02-14
PT810225E (pt) 2001-12-28
DE69706366T2 (de) 2002-05-29
ES2162156T3 (es) 2001-12-16
JPH09316072A (ja) 1997-12-09
DE69706366D1 (de) 2001-10-04
CA2205770A1 (en) 1997-11-30
EP0810225B1 (de) 2001-08-29
EP0810225A1 (de) 1997-12-03
SI0810225T1 (en) 2001-10-31
US20020198387A1 (en) 2002-12-26
US6433179B1 (en) 2002-08-13

Similar Documents

Publication Publication Date Title
ATE204870T1 (de) Verfahren zur herstellung von paroxetine
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE3871190D1 (de) Polymerisationsverfahren und polymerisationskatalysator.
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
ATE223900T1 (de) Verfahren zur herstellung von 4- trifluormethylnicotinsäure
EP0738703A3 (de) Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
ATE207055T1 (de) Verfahren zur herstellung von 4-aryl-3- hydroxymethyl-piperidinen
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ES543154A0 (es) Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico
ATE193281T1 (de) Verfahren zur herstellung von 2-(2- hydroxymethylphenyl)acetamid-derivaten und zwischenprodukte zur herstellung
DE69707860T2 (de) Verfahren zur herstellung von tetrahydroindolizinen
ATE365152T1 (de) Verfahren zur herstellung fluorierter benzoesäuren
DE3767618D1 (de) Verfahren zur herstellung von tetrafluorphthalsaeure.
ATE251135T1 (de) Verfahren zur herstellung von 1-substituierten pyrrol-3-carbonsäure-derivaten
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE131485T1 (de) Herstellung von acylaminomethanphosphonsäuren und acylaminomethanphosphinsäuren
ATE155132T1 (de) Verfahren zur herstellung von amino- thiadiazolylacetylhaliden
ATE555075T1 (de) Verfahren zur herstellung von formylcyclopropancarbonsäureestern
DE69030884D1 (de) Verfahren zur herstellung von norbornan-sulfonamidderivat
ATE234806T1 (de) Verfahren zur herstellung von 2-alkyliden-4- bromacetessigsäureestern
ATE223377T1 (de) Verfahren zur herstellung von difluoracetophenon- derivaten
ATE157357T1 (de) Verfahren zur herstellung von dihydrofuranonderivaten
DE68907032D1 (de) Verfahren zur herstellung von 1,4-ueberbrueckten-cyclohexancarbonsaeure-derivaten und ihre verwendung.
ATE131483T1 (de) Verfahren zur herstellung von penemen
ATE57934T1 (de) Verfahren zur herstellung von griseolinsaeurederivaten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties